Navigation Links
Medivation Announces Fourth Quarter and Year-End 2008 Teleconference and Webcast on March 16, 2009
Date:3/9/2009

SAN FRANCISCO, March 9 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today announced that it will host a teleconference and webcast with management to discuss fourth quarter and year-end 2008 financial results and provide a general business update on Monday, March 16, 2009, at 4:30 p.m. Eastern Time. A press release for the fourth quarter and year ended December 31, 2008 will be released after markets close on March 16, 2009.

Interested parties may call 877-718-5104 from the U.S. or +1-719-325-4794 internationally. Individuals interested in listening to the live call via webcast may do so by visiting http://www.medivation.com. A replay of the webcast will be available on the Company's website for 30 days.

About Medivation

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. In September 2008, Medivation announced a global agreement with Pfizer Inc to develop and commercialize Dimebon for the treatment of Alzheimer's and Huntington's diseases. With Pfizer, the Company is conducting a broad Dimebon clinical development program, including a pivotal and confirmatory Phase 3 trial, known as the CONNECTION study, in patients with mild-to-moderate Alzheimer's disease. The program also includes additional trials planned to begin this year in Alzheimer's disease, as well as further development of Dimebon in patients with mild-to-moderate Huntington's disease. In addition, a Phase 1-2 clinical trial of MDV3100 in patients with castration-resistant (also known as hormone-refractory) prostate canc
'/>"/>

SOURCE Medivation, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Medivation to Host Conference Call and Slide Presentation at 4:30 p.m. EST Wednesday, February 25, to Discuss New MDV3100 Efficacy and Safety Data From Trial in Castration-Resistant Prostate Cancer Patients
2. Medivation Announces Participation in Upcoming Conferences
3. Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference
4. Medivation Announces Participation in Upcoming Conferences
5. Medivation to Present at Cowen and Companys 28th Annual Health Care Conference
6. Medivation Plans to Initiate Pivotal Confirmatory Phase 3 Trial of Dimebon(TM) for Alzheimers Disease in Second Quarter of 2008
7. Medivation to Announce Early Positive Data from Phase 1-2 Hormone Refractory Prostate Cancer Trial and Host Conference Call and Webcast on Monday, November 5, 2007
8. National Western Life Announces 2008 Fourth Quarter and 2008 Earnings
9. Celebrity Chef Cat Cora Announces First Pregnancy
10. National Patient Advocate Foundation Announces 2009 Elections of Health Policy Leaders to Executive Board of Directors
11. CEL-SCI Announces Exclusive Licensing Agreement for Cancer Drug Multikine(R) for Republic of South Africa

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...le Dental (RTDental), a leading dental group pract... expansion of its services to include LUMINEERS by... , Durham, NC (PRWEB) ... that Dr. Doug Macmillan, an experienced LUMINEER...ced training seminar. RTDental’s ability to...
(Date:11/25/2009)...re-FirstCall/-- OnyxPharmaceuticals,Inc.(Nasdaq: ...toreventsinDecember: ,, ASHBriefing ,, ...ncipalinvestigatorswilldiscussdatapresentationssur...plemyeloma,asfeaturedatthe51stAmericanSocietyofHem...,LA.Theteleconferencewillbeginat9:00a.m.CT/10:00a....
(Date:11/25/2009)...wswire/--TheBlackAIDSInstituterecentlyheldBoardofD...010. ,, ThenewBoardMembersareahighlydiversegrou...e,governmenthealthprograms,editorial,andbusinessen...rsonalbackgroundsincludingbothheterosexualandgayBl...esentingmultipleagegroups. ,, (Photo: http://ww...
(Date:11/25/2009)...of a collaboration between UCLA engineers and phys...10 million Americans who suffer from peripheral ar... the arteries, peripheral arterial disease, or PAD...d arteries reduce blood flow to the limbs. The con...se, heart attack and stroke, and its progression c...
(Date:11/25/2009)... to overlook needed care, study finds , ,...s depression can worsen her child,s asthma, U.S. r...of 262 black mothers and their children found that...ms had more frequent asthma symptoms, while childr...ess frequent asthma symptoms. , The Johns Hopki...
Breaking Medicine News(10 mins):Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Mom's Depression May Worsen Child's Asthma 2
...s been detected in Asia, the British government an...re sites for any evidence of bird flu. The dea...s, reservoirs and parks will be brought to the not... from the University of Hong Kong have detected a ...
...ptoms of schizophrenia can be relieved by music th... London conducted a study in 4 hospitals and found...ents when they were encouraged to express themselv...n people are fairly stable," said Dr Mike Crawford...
...today welcomed the Stern Review as a timely and au...mpact of climate change on the world’s human popul... now. Commissioned by the UK Government and p...ortant he has ever received. Dr Haikerwal sa...
...om umbilical cord blood stem cells for the first t...eed for animal experiments for drug testing. A...ize of a 1p coin, is just the initial phase of gen... association with experts from the U.S. The artifi...
...n's agency has launched the first online game in K... HIV and Aids. The game is named as "What woul...ough several different scenarios so that he import...Aids. Africa has the largest number of HIV inf...
...nfant’s risk of cot death or sudden infant death s...hat affect breathing and temperature control. // ...s who died of SIDS. The findings were published in...ocessing of the chemical called serotonin in the b...
Other Medicine News:Health News:A Timely Reminder Of Devastating Health Impact Of Climate Change 2Health News:Artificial Liver from Cord Blood Stem cells 2Health News:Brain stem Defects associated with SIDS 2
(Date:11/25/2009)...RIDGEWATER,N.J.,Nov.25/PRNewswire/--TheFDAgrantedt...blets,anon-nucleosidereversetranscriptaseinhibitor...edforuseintreatment-experiencedadultswhoareexperie...NNRTIandotherantiretroviral(ARV)agents.Thetraditio...sknownasDUET-1andDUET-2.INTELENCEiscurrentlymarket...
(Date:11/25/2009)...ASKINGRIDGE,N.J.,Nov.25/PRNewswire/--RegadoBioscie...ntithromboticaptamerswithactivecontrolagents,annou...ntingatthePiperJaffray21stAnnualHealthCareConferen...resentationwillbegivenat1:10pm(EST)onTuesday,Decem...withemphasisontheleaddevelopmentprogram,theanticoa...
(Date:11/25/2009)...NIONCITY,Calif.,Nov.25/PRNewswire-FirstCall/--Abax...facturingpoint-of-carebloodanalysissystems,announc...officer,willpresentatthe21stAnnualPiperJaffrayHeal...m.ET.TheconferencewillbeheldattheNewYorkPalaceHote...velops,manufacturesandmarketsportablebloodanalysis...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2A WIT Technologies Releases World 26apos 3Bs First Low Cost C Stamp 28TM 29 Based Biotechnology Laboratory in a Box 12572 1A WIT Technologies Releases World 26apos 3Bs First Low Cost C Stamp 28TM 29 Based Biotechnology Laboratory in a Box 12572 2Polycom and AMD Global Telemedicine Inc To Deliver Integrated Visual And Voice Telehealth Capability To Clinicians On The Go 48554 1Polycom and AMD Global Telemedicine Inc To Deliver Integrated Visual And Voice Telehealth Capability To Clinicians On The Go 48554 2Polycom and AMD Global Telemedicine Inc To Deliver Integrated Visual And Voice Telehealth Capability To Clinicians On The Go 48554 3Want to Learn How to Testify 3F New Home Study Course by Practicing Physician Teaches Medical Malpractice Defendants and Physicians How to be Effectiv 48551 1Want to Learn How to Testify 3F New Home Study Course by Practicing Physician Teaches Medical Malpractice Defendants and Physicians How to be Effectiv 48551 2Want to Learn How to Testify 3F New Home Study Course by Practicing Physician Teaches Medical Malpractice Defendants and Physicians How to be Effectiv 48551 3
...6 D-Pharm announced today that it,has submitted I...to the US,Food and Drug Administration (FDA), for ...acute ischemic stroke patients. D-Pharm plans to i...view of the IND and SPA. Recently,D-Pharm also obt...s Agency,(EMEA) on the development strategy for DP...
...ikely to Suffer from Lower Body Injuries , , CINC..., obese children are significantly more likely to ...and legs. The Cincinnati Children,s Hospital Medic...if different body parts are injured in obese child...ion strategies can be developed, was presented May...
Other Medicine Technology:D-Pharm Submits Investigational New Drug Application and Special Protocol Assessment to the FDA for Phase III Trial of DP-b99 in Acute Stroke Patients 2D-Pharm Submits Investigational New Drug Application and Special Protocol Assessment to the FDA for Phase III Trial of DP-b99 in Acute Stroke Patients 3The Injured Obese Child: Let's Give Him Some Ankle Support 2The Injured Obese Child: Let's Give Him Some Ankle Support 3
...ctious disease ELISA products make us a leader in ...er integration into the busy laboratory, our Infec...iability and run-to-run consistency. Our Infectiou...ssays for a wide range of serological assays inclu...
...ctious disease ELISA products make us a leader in ...er integration into the busy laboratory, our Infec...iability and run-to-run consistency. Our Infectiou...ssays for a wide range of serological assays inclu...
...ctious disease ELISA products make us a leader in ...er integration into the busy laboratory, our Infec...iability and run-to-run consistency. Our Infectiou...ssays for a wide range of serological assays inclu...
...ctious disease ELISA products make us a leader in ...er integration into the busy laboratory, our Infec...iability and run-to-run consistency. Our Infectiou...ssays for a wide range of serological assays inclu...
Medicine Products: